Macrophages in immunoregulation and therapeutics

S Chen, AFUH Saeed, Q Liu, Q Jiang, H Xu… - … and Targeted Therapy, 2023 - nature.com
Macrophages exist in various tissues, several body cavities, and around mucosal surfaces
and are a vital part of the innate immune system for host defense against many pathogens …

[HTML][HTML] The macrophage polarization in inflammatory dermatosis and its potential drug candidates

Q Sun, S Hu, Z Lou, J Gao - Biomedicine & Pharmacotherapy, 2023 - Elsevier
Inflammatory dermatosis is characterized by persistent inflammatory infiltration and hard
repair of diseased skin. As a member of the human innate immune cells, macrophages …

Back to the future: targeting the extracellular matrix to treat systemic sclerosis

A Leask, A Naik, RJ Stratton - Nature Reviews Rheumatology, 2023 - nature.com
Fibrosis is the excessive deposition of a stable extracellular matrix (ECM); fibrotic tissue is
composed principally of highly crosslinked type I collagen and highly contractile …

Epiregulin is a dendritic cell–derived EGFR ligand that maintains skin and lung fibrosis

ID Odell, H Steach, SB Gauld, L Reinke-Breen… - Science …, 2022 - science.org
Immune cells are fundamental regulators of extracellular matrix (ECM) production by
fibroblasts and have important roles in determining extent of fibrosis in response to …

[HTML][HTML] Non-classical circulating monocytes expressing high levels of microsomal prostaglandin E2 synthase-1 tag an aberrant IFN-response in systemic sclerosis

G Villanueva-Martin, M Acosta-Herrera… - Journal of …, 2023 - Elsevier
Systemic sclerosis (SSc) is a complex disease that affects the connective tissue, causing
fibrosis. SSc patients show altered immune cell composition and activation in the peripheral …

Macrophage: key player in the pathogenesis of autoimmune diseases

S Yang, M Zhao, S Jia - Frontiers in Immunology, 2023 - frontiersin.org
The macrophage is an essential part of the innate immune system and also serves as the
bridge between innate immunity and adaptive immune response. As the initiator and …

Potential angiogenic, immunomodulatory, and antifibrotic effects of mesenchymal stem cell-derived extracellular vesicles in systemic sclerosis

K Zhao, C Kong, N Shi, J Jiang, P Li - Frontiers in Immunology, 2023 - frontiersin.org
Systemic sclerosis (SSc) is an intricate systemic autoimmune disease with pathological
features such as vascular injury, immune dysregulation, and extensive fibrosis of the skin …

Role of cellular senescence in the pathogenesis of systemic sclerosis

PS Tsou, B Shi, J Varga - Current opinion in rheumatology, 2022 - journals.lww.com
There is increasing evidence implicating cellular senescence in SSc. The mechanisms
underlying premature cellular senescence in SSc, and its potential role in pathogenesis …

Emerging diagnostic and therapeutic challenges for skin fibrosis in systemic sclerosis

D Abraham, A Lescoat, R Stratton - Molecular Aspects of Medicine, 2024 - Elsevier
Systemic sclerosis (also called scleroderma, SSc) is a chronic autoimmune disorder
characterized by excessive collagen deposition leading to skin fibrosis and various internal …

PARP inhibition promotes endothelial‐like traits in melanoma cells and modulates pericyte coverage dynamics during vasculogenic mimicry

M Fernández‐Cortés, D Delgado‐Bellido… - The Journal of …, 2023 - Wiley Online Library
Vasculogenic mimicry (VM) describes the ability of highly aggressive tumor cells to develop
pseudovascular structures without the participation of endothelial cells. PARP1 is implicated …